Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
NUDT6
Introduction
Nucleoside diphosphate-linked moiety X motif 6 is a protein that in humans is encoded by the NUDT6 gene.[1][2][3]
FGF2 (MIM 134920) is a highly conserved, multifunctional heparin-binding growth factor involved in neuroectoderm development, angiogenesis, and wound healing. Elevated levels of FGF2 are associated with proliferation of smooth muscle in atherosclerosis and with proliferation of tumors. The FGF2 antisense gene, NUDT6, may regulate FGF2 expression.[supplied by OMIM][3]
References
References
- ↑ Murphy PR, Knee RS (Jan 1995). “Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene”. Mol Endocrinol. 8 (7): 852–9. doi:10.1210/me.8.7.852. PMID 7984147.
- ↑ Gagnon ML, Moy GK, Klagsbrun M (Apr 1999). “Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells”. J Cell Biochem. 72 (4): 492–506. doi:10.1002/(SICI)1097-4644(19990315)72:4<492::AID-JCB5>3.0.CO;2-H. PMID 10022609.
- ↑ 3.0 3.1 “Entrez Gene: NUDT6 nudix (nucleoside diphosphate linked moiety X)-type motif 6”.
Further reading
Further reading
- Knee RS, Pitcher SE, Murphy PR (1995). “Basic fibroblast growth factor sense (FGF) and antisense (gfg) RNA transcripts are expressed in unfertilized human oocytes and in differentiated adult tissues”. Biochem. Biophys. Res. Commun. 205 (1): 577–83. doi:10.1006/bbrc.1994.2704. PMID 7999082.
- Li AW, Too CK, Knee R, et al. (1998). “FGF-2 antisense RNA encodes a nuclear protein with MutT-like antimutator activity”. Mol. Cell. Endocrinol. 133 (2): 177–82. doi:10.1016/S0303-7207(97)00148-2. PMID 9406864.
- Asa SL, Ramyar L, Murphy PR, et al. (2001). “The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production”. Mol. Endocrinol. 15 (4): 589–99. doi:10.1210/me.15.4.589. PMID 11266510.
- Duplan SM, Théorêt Y, Kenigsberg RL (2002). “Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant”. Clin. Cancer Res. 8 (1): 246–57. PMID 11801566.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Sheng Z, Lewis JA, Chirico WJ (2004). “Nuclear and nucleolar localization of 18-kDa fibroblast growth factor-2 is controlled by C-terminal signals”. J. Biol. Chem. 279 (38): 40153–60. doi:10.1074/jbc.M400123200. PMID 15247275.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Vasilescu J, Zweitzig DR, Denis NJ, et al. (2007). “The proteomic reactor facilitates the analysis of affinity-purified proteins by mass spectrometry: application for identifying ubiquitinated proteins in human cells”. J. Proteome Res. 6 (1): 298–305. doi:10.1021/pr060438j. PMID 17203973.
- Pezzatini S, Morbidelli L, Solito R, et al. (2007). “Nanostructured HA crystals up-regulate FGF-2 expression and activity in microvascular endothelium promoting angiogenesis”. Bone. 41 (4): 523–34. doi:10.1016/j.bone.2007.06.016. PMID 17681892.